Naltrexone 50 Mg

DRUG3 trials

Sponsors

Brown University, Medical University of South Carolina, INSYS Therapeutics Inc

Conditions

Alcohol DependenceAlcoholismPain

Phase 1

Pharmacokinetic Study of Fentanyl 400 µg Sublingual Spray, Actiq® 400 µg Transmucosally, and Fentanyl Citrate Injection 100 µg Intravenously (iv)

CompletedNCT01780233

INSYS Therapeutics IncPain

Start: 2007-04-30End: 2007-05-31Updated: 2013-01-31

Phase 4

Naltrexone, Craving, and Drinking

CompletedNCT00006203

Brown UniversityAlcoholism

End: 2005-05-31Updated: 2025-06-13

Genetic and Brain Mechanisms of Naltrexone's Treatment Efficacy for Alcoholism

CompletedNCT00920829

Medical University of South CarolinaAlcohol Dependence

Start: 2009-06-30End: 2015-12-31Updated: 2018-07-10

Related Papers

Single-dose pharmacokinetics of fentanyl sublingual spray and oral transmucosal fentanyl citrate in healthy volunteers: a randomized crossover study.

2013-03-0117 citations